All objective long investors are intrigued with additional uses for DR-70. It will not be long before an enterprising pharma company capitalizes on its potential.
DR-70 has sat idle for too long due to an under capitalized RXPC mired down in corporate problems- but not much longer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.